Patents by Inventor Ronald Ross Watson

Ronald Ross Watson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220062366
    Abstract: The invention relates to a feijoa fruit extract. In particular the invention relates to therapeutic uses of a feijoa fruit extract, processes for preparing the extract, and compositions comprising the extract. The feijoa fruit extract of the invention can be used in the treatment and prevention of rheumatoid arthritis and Type-2 diabetes.
    Type: Application
    Filed: June 15, 2021
    Publication date: March 3, 2022
    Inventors: Lai Yeap Foo, Ronald Ross Watson
  • Patent number: 11065292
    Abstract: The invention relates to a feijoa fruit extract. In particular the invention relates to therapeutic uses of a feijoa fruit extract, processes for preparing the extract, and compositions comprising the extract. The feijoa fruit extract of the invention can be used in the treatment and prevention of rheumatoid arthritis and Type-2 diabetes.
    Type: Grant
    Filed: November 1, 2018
    Date of Patent: July 20, 2021
    Assignees: CALLAGHAN INNOVATION, SOUTHWEST SCIENTIFIC EDITING & CONSULTING L.L.C.
    Inventors: Lai Yeap Foo, Ronald Ross Watson
  • Publication number: 20190076498
    Abstract: The invention relates to a feijoa fruit extract. In particular the invention relates to therapeutic uses of a feijoa fruit extract, processes for preparing the extract, and compositions comprising the extract. The feijoa fruit extract of the invention can be used in the treatment and prevention of rheumatoid arthritis and Type-2 diabetes.
    Type: Application
    Filed: November 1, 2018
    Publication date: March 14, 2019
    Inventors: Lai Yeap Foo, Ronald Ross Watson
  • Patent number: 10149880
    Abstract: The invention relates to a feijoa fruit extract. In particular the invention relates to therapeutic uses of a feijoa fruit extract, processes for preparing the extract, and compositions comprising the extract. The feijoa fruit extract of the invention can be used in the treatment and prevention of rheumatoid arthritis and Type-2 diabetes.
    Type: Grant
    Filed: June 10, 2013
    Date of Patent: December 11, 2018
    Assignees: CALLAGHAN INNOVATION, SOUTHWEST SCIENTIFIC EDITING & CONSULTING
    Inventors: Lai Yeap Foo, Ronald Ross Watson
  • Publication number: 20150157678
    Abstract: The invention relates to a feijoa fruit extract. In particular the invention relates to therapeutic uses of a feijoa fruit extract, processes for preparing the extract, and compositions comprising the extract. The feijoa fruit extract of the invention can be used in the treatment and prevention of rheumatoid arthritis and Type-2 diabetes.
    Type: Application
    Filed: June 10, 2013
    Publication date: June 11, 2015
    Inventors: Lai Yeap Foo, Ronald Ross Watson
  • Patent number: 7998926
    Abstract: Dimers of a peptide from the T-cell receptor (Cys Lys Pro Ile Ser Gly His Asn Ser Leu Phe Trp Tyr Arg Gln Thr) (SEQ ID NO:1) are disclosed for preventing the progression to AIDS in an animal model. Methods for delaying the progression to AIDS and restoring normal immunological responses in an animal model following infection are shown and comprise administering through various systemic routes dimeric T-cell receptor peptide V? CDR1 to restore normal levels of Th1 cytokines interleukin 2 and interferon-?, which are suppressed following infection, and those of Th2 derived cytokines interleukin 5, interleukin 6, interleukin 10, and immunoglobulin G, which are stimulated following infection.
    Type: Grant
    Filed: May 17, 2002
    Date of Patent: August 16, 2011
    Assignee: The Arizona Boad of Regents on Behfl of the University of Arizona
    Inventors: John Jacob Marchalonis, Ronald Ross Watson
  • Patent number: 7740888
    Abstract: An extract of passion fruit is prepared. The extract has the effect of lowering blood pressure and serum nitric oxide levels in mammals. The extract also provides a hepatoprotective effect, as well as antioxidant and anti-inflammatory effects in mammals. A novel compound was identified in the extract and given the name edulilic acid.
    Type: Grant
    Filed: April 10, 2008
    Date of Patent: June 22, 2010
    Assignees: Industrial Research Limited, Southwest Scientific Editing & Consulting LLC
    Inventors: Lai Yeap Foo, Yinrong Lu, Ronald Ross Watson
  • Patent number: 7691423
    Abstract: An extract of the skin or peel of passion fruit is prepared. The extract has the effect of ameliorating the symptoms of inflammation disorders, including asthma and osteoarthritis, in mammals, including humans, when administered in an effective amount.
    Type: Grant
    Filed: July 23, 2008
    Date of Patent: April 6, 2010
    Assignees: Industrial Research Limited, Southwest Scientific Editing
    Inventors: Lai Yeap Foo, Yinrong Lu, Ronald Ross Watson
  • Patent number: 7687089
    Abstract: An extract of passion fruit is prepared. The extract has the effect of lowering blood pressure and serum nitric oxide levels in mammals. The extract also provides a hepatoprotective effect, as well as antioxidant and anti-inflammatory effects in mammals. A novel compound was identified in the extract and given the name edulilic acid.
    Type: Grant
    Filed: April 10, 2008
    Date of Patent: March 30, 2010
    Assignees: Industrial Research Limited, Southwest Scientific Editing
    Inventors: Lai Yeap Foo, Yinrong Lu, Ronald Ross Watson
  • Publication number: 20090041878
    Abstract: An extract of passion fruit is prepared. The extract has the effect of lowering blood pressure and serum nitric oxide levels in mammals. The extract also provides a hepatoprotective effect, as well as antioxidant and anti-inflammatory effects in mammals. A novel compound was identified in the extract and given the name edulilic acid.
    Type: Application
    Filed: April 10, 2008
    Publication date: February 12, 2009
    Inventors: Lai Yeap Foo, Yinrong Lu, Ronald Ross Watson
  • Publication number: 20090022832
    Abstract: An extract of the skin or peel of passion fruit is prepared. The extract has the effect of ameliorating the symptoms of inflammation disorders, including asthma and osteoarthritis, in mammals, including humans, when administered in an effective amount.
    Type: Application
    Filed: July 23, 2008
    Publication date: January 22, 2009
    Inventors: Lai Yeap Foo, Yinrong Lu, Ronald Ross Watson
  • Publication number: 20080305194
    Abstract: An extract of passion fruit is prepared. The extract has the effect of lowering blood pressure and serum nitric oxide levels in mammals. The extract also provides a hepatoprotective effect, as well as antioxidant and anti-inflammatory effects in mammals. A novel compound was identified in the extract and given the name edulilic acid.
    Type: Application
    Filed: April 10, 2008
    Publication date: December 11, 2008
    Inventors: Lai Yeap Foo, Yinrong Lu, Ronald Ross Watson
  • Patent number: 7390517
    Abstract: An extract of passion fruit is prepared. The extract has the effect of lowering blood pressure and serum nitric oxide levels in mammals. The extract also provides a hepatoprotective effect, as well as antioxidant and anti-inflammatory effects in mammals. A novel compound was identified in the extract and given the name edulilic acid.
    Type: Grant
    Filed: April 4, 2005
    Date of Patent: June 24, 2008
    Inventors: Lai Yeap Foo, Yinrong Lu, Ronald Ross Watson
  • Publication number: 20040248192
    Abstract: Dimers of a peptide from the T-cell receptor (Cys Lys Pro Ile Ser Gly His Asn Ser Leu Phe Trp Tyr Arg Gln Thr) are disclosed for preventing the progression to AIDS in an animal model. Methods for delaying the progression to AIDS and restoring normal immunological responses in an animal model following infection are shown and comprise administering through various systemic routes dimeric T-cell receptor peptide V&bgr; CDR1 to restore normal levels of Th1 cytokines interleukin 2 and interferon-&ggr;, which are suppressed following infection, and those of Th2 derived cytokines interleukin 5, interleukin 6, interleukin 10, and immunoglobulin G, which are stimulated following infection.
    Type: Application
    Filed: July 28, 2004
    Publication date: December 9, 2004
    Inventors: Jacob John Marchalonis, Ronald Ross Watson